Whitehawk Therapeutics (WHWK) Interest Coverage Ratio (2010 - 2024)
Whitehawk Therapeutics (WHWK) reported Interest Coverage Ratio of 352.97 for Q3 2024, down 14.7% year-over-year from 413.79 in Q4 2023, and down 31.37% quarter-over-quarter from 268.69 in Q2 2024.
Whitehawk Therapeutics (WHWK) Interest Coverage Ratio (2010 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 12 years of Interest Coverage Ratio data on file, last reported at 352.97 in Q3 2024.
- Interest Coverage Ratio for Q3 2024 came in at 352.97, down 14.7% year-over-year; the trailing twelve-month figure through Jun 2025 was 2692.87 (down 780.36% YoY), and the FY2024 annual result was 438.04, down 40.67% from the prior year.
- Interest Coverage Ratio retreated to 352.97 in Q3 2024 per WHWK's latest filing, from 268.69 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 29.59 in Q4 2020 and troughed at 556.12 in Q3 2021.
- A 5-year average of 243.66 and a median of 279.74 in 2021 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2022: Interest Coverage Ratio sank 4682.26% in 2021, then surged 53.38% in 2022.
- A 5-year view of Interest Coverage Ratio shows it stood at 29.59 in 2020, then slumped by 1045.33% to 279.74 in 2021, then gained by 2.97% to 271.44 in 2022, then retreated by 14.49% to 310.77 in 2023, then declined by 13.58% to 352.97 in 2024.
- Business Quant data shows WHWK's Interest Coverage Ratio at 352.97 in Q3 2024, 268.69 in Q2 2024, and 336.41 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -352.97 |
| Jun 30, 2024 | -268.69 |
| Mar 31, 2024 | -336.41 |
| Dec 31, 2023 | -310.77 |
| Sep 30, 2023 | -307.74 |
| Jun 30, 2023 | -336.98 |
| Mar 31, 2023 | -290.09 |
| Dec 31, 2022 | -271.44 |
| Sep 30, 2022 | -259.24 |
| Jun 30, 2022 | -316.55 |
| Mar 31, 2022 | -238.17 |
| Dec 31, 2021 | -279.74 |
| Sep 30, 2021 | -556.12 |
| Jun 30, 2021 | -17.07 |
| Mar 31, 2021 | -18.25 |
| Dec 31, 2020 | 29.59 |
| Sep 30, 2020 | -11.63 |
| Dec 31, 2016 | -1,285.65 |
| Sep 30, 2016 | -1,949.60 |
| Jun 30, 2016 | -1,721.37 |